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We have previously shown that two synthetic antimicrobial peptides with alternating α- and β-amino acid residues, designated simply as α/β-
peptide I and α/β-peptide II, had toxicity toward bacteria and affected the morphology of bacterial membranes in a manner that correlated with
their effects on liposomes with lipid composition similar to those of the bacteria. In the present study we account for the weak effects of α/β-
peptide I on liposomes or bacteria whose membranes are enriched in phosphatidylethanolamine (PE) and why such membranes are particularly
susceptible to damage by α/β-peptide II. The α/β-peptide II has marked effects on unilamellar vesicles enriched in PE causing vesicle aggregation
and loss of their internal aqueous contents. The molecular basis of these effects is the ability of α/β-peptide II to induce phase segregation of
anionic and zwitterionic lipids as shown by fluorescence and differential scanning calorimetry. This phase separation could result in the formation
of defects through which polar materials could pass across the membrane as well as form a PE-rich membrane domain that would not be a stable
bilayer. α/β-Peptide II is more effective in this regard because, unlike α/β-peptide I, it has a string of two or three adjacent cationic residues that
can interact with anionic lipids. Although α/β-peptide I can destroy membrane barriers by converting lamellar to non-lamellar structures, it does
so only weakly with unilamellar vesicles or with bacteria because it is not as efficient in the aggregation of these membranes leading to the
bilayer–bilayer contacts required for this phase conversion. This study provides further understanding of why α/β-peptide II is more toxic to
micro-organisms with a high PE content in their membrane as well as for the lack of toxicity of α/β-peptide I with these cells, emphasizing the
potential importance of the lipid composition of the cell surface in determining selective toxicity of anti-microbial agents.
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It is well known that the chemical and physical nature of the
cell surface differs widely among different cell types. MuchAbbreviations: LUV, large unilamellar vesicle; MLV, multilamellar vesicles;
DO, dioleoyl; DP, dipalmitoyl; PC, phosphatidylcholine; PE, phosphatidyleth-
anolamine; PG, phosphatidylglycerol; CL, tetraoleoyl cardiolipin; L/P, lipid toα/
β-peptide molar ratio; C6-NBD-PE, 1-Myristoyl-2-[6-[(7-nitro-2-1,3-benzoxadia-
zol-4-yl)amino]hexanoyl]-sn-Glycero-3-Phosphoethanolamine; C6-NBD-PC,
1-myristoyl-2[6-(7-nitro-2,1,3-benzoxadiazol-4-yl) )amino)caproyl]sn-glycero-
3-phosphocholine; C6-NBD-PG, 1-Myristoyl-2-[6-[(7-nitro-2-1,3-benzoxadia-
zol-4-yl)amino]hexanoyl]-sn-Glycero-3-[Phospho-rac-(1-glycerol)]; Rh-PE,
N-(lissamine Rhodamine B sulfonyl)phosphatidylethanolamine; FRET, fluores-
cence resonance energy transfer; DSC, differential scanning calorimetry
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doi:10.1016/j.bbamem.2006.01.018attention has been given to the greater extent of exposure of
anionic charge on the surface of bacterial cells compared with
mammalian cells. This negative charge is the basis of the
microbial specificity of many antimicrobial peptides, which are
cationic and therefore bind preferentially to the anionic surface
of bacteria. There are also several studies demonstrating lipid
head group specificity, apart from charge, in the interactions of
antimicrobial peptides with model membranes, see for example
[1,2]. However, this description is not complete since it is
known that many antimicrobial peptides show selective toxicity
for certain bacterial species. Furthermore, the species most
sensitive to a particular agent differs for different antimicrobial
peptides. Hence, there must be other factors determining
toxicity in addition to the charge on the cell surface. One
consideration is that not all of the antimicrobial peptides act by
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membrane must play some role in targeting of peptides to
different cell types, irrespective of the mechanism of cell killing.
Gram positive and Gram negative bacteria differ fundamentally
in the morphology of their surfaces (Fig. 1). Gram negative
bacteria have an outer membrane that is rich in lipopolysac-
charides in addition to the cytoplasmic membrane. These
bacteria also have a peptidoglycan layer between the two
membranes. In contrast, peptidoglycan makes up the cell wall of
Gram positive bacteria and contains teichoic and lipoteichoic
acids. The peptidoglycan layer of Gram positive bacteria is
much thicker, 20–80 nm, than in Gram negative bacteria where
it is found to be about ten times smaller [4]. Neither the outer
membrane of Gram negative bacteria nor the cell wall of Gram
positive bacteria are generally considered to be a major barrier
to the penetration of peptides into the cell. The major exceptions
to this are peptides that bind to components of the cell wall or
outer membrane, which is not the case for the peptides used in
the present study [5].
We have been studying a pair of oligomers that contains
sequentially alternating α- and β-amino acid residues (“α/β-
peptides”), I and II (Fig. 2). The peptides are shown both as a
linear sequence. There is evidence that this class of peptides
forms i, i+4 C_O–H–N backbone hydrogen bonds, which
occur in alternating 14- and 15-membered rings (“14/15-helix”)
[6]. Although α/β-peptides I and II have identical chemicalFig. 1. Schematic representation of the membrane organization of Gram positive and
stanford.edu/~amatin/MatinLabHomePage/Student%20Presentation/Zomora/Zamoracomposition and identical charge, they have very different
potencies with different cell types (Table 1). α/β-Peptide II is
much more toxic to E. coli than is α/β−peptide I, while α/β-
peptide I is more lytic toward human erythrocytes. The
phospholipid composition of cell membranes can differ
dramatically, even among bacteria (Table 2). Human erythro-
cytes exhibit a large difference in the lipid composition of the
two monolayers of the cell membrane bilayer, with the
cytoplasmic surface having most of the phosphatidylethanol-
amine (PE) and anionic lipid, while the extracellular monolayer
has essentially all of the sphingomyelin (SM) and is devoid of
anionic lipid. In the case of E. coli (Gram negative), the major
lipid in both monolayers is PE, while for B. subtilis (Gram
positive) the major lipids are the anionic phosphatidylglycerol
(PG) and cardiolipin (CL). There are thus major differences in
the phospholipid composition of the exposed membrane surface
among these three cell types (Gram negative bacteria, Gram
positive bacteria, and erythrocytes), and even larger differences
between the two types of bacteria themselves.
There is a phenomenological correlation between the toxicity
of α/β-peptides I and II toward these three cell types and the
rate of aqueous contents leakage induced by these peptides in
liposomes with a lipid composition corresponding to that of a
particular cell type [5]. Thus α/β-peptide I is more hemolytic
(Table 1) and induces greater leakage in liposomes devoid of
anionic lipid, while α/β-peptide II is toxic to E. coli and causesGram negative bacteria. Diagrams adapted from the following URL: http://www.
%20handout.pdf.
Fig. 2. Structures of α/β-peptides I and II.
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β-peptide I, relative to α/β-peptide II, toward membranes
containing only zwitterionic lipids presumably arises because
α/β-peptide I has a greater net hydrophobicity than does α/β-
peptide II. This physicochemical difference is manifested in
reverse-phase HPLC mobility: α/β-peptide I is much more
strongly retained on the hydrophobic stationary phase than is α/
β-peptide II [5]. The difference in net hydrophobicities can be
rationalized in terms of the expected folding of α/β-peptides I
and II. Both should form a helix containing i, i+4 C_O–H–N
hydrogen bonds (“14/15-helix”). In this conformation, α/β-
peptide I should display one large hydrophobic patch, but the
hydrophobic side chains of sequence isomer α/β-peptide II
should be clustered into smaller patches.
We have previously shown that α/β-peptide II causes closer
approach of adjacent membranes, both with model vesicles as
well as between the inner and outer membranes of E. coli [5]. In
the present report we investigate further the differences in the
interactions of these two peptides with PE-rich membranes, and
we show that these differences can explain variations in the
activities of these molecules toward cells.
2. Materials and methods
2.1. Materials
Phospholipids, including the fluorescently labeled lipids, were purchased
from Avanti Polar Lipids (Alabaster, AL). The synthesis and purification of α/β-
Peptide I and II have been described [6].
2.2. Preparation of LUV
Lipid films were made by dissolving appropriate amounts of lipid in a
mixture of chloroform/methanol, 2/1 (v/v), followed by solvent evaporation
under nitrogen to deposit the lipid as a film on the wall of a test tube. Final traces
of solvent were removed in a vacuum chamber attached to a liquid nitrogen trap,
for 2–3 h. Dried films were kept under Argon gas at −30 °C if not used
immediately. Films were hydrated with 10 mM HEPES, 0.14 M NaCl, 1 mMTable 1
Antimicrobial and hemolytic activities of α/β-peptides a
Peptide E. coli b B. subtilis b Hemolysis c
α/β-Peptide I >100 6.3 1.6
α/β-Peptides II 6.3 6.3 50
a From Schmitt et al. [6].
b Minimum Inhibitory Concentration (μg/mL).
c Maximum concentration without hemolysis (μg/mL).EDTA (HEPES buffer) and vortexed extensively at room temperature. The lipid
suspension was then subjected to five cycles of freezing and thawing and the
homogeneous lipid suspensions were then further processed by 10 passes
through two stacked 0.1 μm polycarbonate filters (Nucleopore Filtration
Products, Pleasanton, CA) in a high pressure barrel extruder (Lipex
Biomembranes, Vancouver, BC), at room temperature to extrude LUVs. The
size of the LUVs were monitored with quasi-elastic light scattering, as
previously described [7], and found to have a diameter of 90±10 Å. The vesicles
were kept on ice and used within a few hours of preparation. Lipid phosphorus
was determined by the method of Ames [8].
2.3. Liposome aggregation measured by turbidity changes
Absorbance at 436 nm was measured in a Cary 50 Bio UV-visible
spectrophotometer, as a function of time, after peptide addition to a suspension
of 50 μMLUVs composed of DOPE:DOPG (2:1) in HEPES buffer, pH 7.4. The
rate of change of turbidity was measured at 30 °C, with constant stirring. Zero
absorbance was set with LUVs, prior to addition of peptide.
2.4. Liposome aggregation measured by confocal fluorescence
microscopy
Films composed of DOPE:DOPG (2:1) containing 1 mol% of Rh-PE were
hydrated with HEPES buffer pH 7.4 and LUVs were made by extrusion. To a
50 μM suspension of LUVs, 10 μM α/β-peptide I or II in HEPES buffer were
added. A drop of this mixture was placed in a glass slide, overlaid with a
coverslip and then visualized by confocal fluorescence microscopy using a Zeiss
Axiovert laser scanning confocal inverted microscope (LSM-510). Fluorescence
from Rh-PE was monitored using a 505–530 nm bandpass filter in the excitation
path. Images were analyzed with the program Zeiss LSM 5 Image Browser
version 2.80.1123.
2.5. Fluorescence assay for the lateral segregation of lipids
LUVs were prepared in HEPES buffer from lipid films containing 1 mol%
N-Rh-PE and 1 mol% C6-NBD-PG, C6-NBD-PC or C6-NBD-PE. Fluorescence
spectra were measured as a function of time with the liposomes contained in
cuvettes in 2 mL HEPES buffer, pH 7.4, 25 °C. The excitation wavelength was
465 nm and a 500 nm cut off filter was used with a 4-nm bandpass in excitation
and emission. 50 μM LUVs were titrated with incremental amounts of peptides
in HEPES buffer solution. The spectra were measured between 500 nm and
650 nm after each addition of peptide.Table 2
Major phospholipid components
Membrane % Total phospholipid
PE PG CL PC SM
E. coli inner membrane [29] 80 15 – – –
B. subtilis cell membrane [30] 12 70 4 – –
Human erythrocyte [31] 29 (13) a – 30 27
a Total anionic lipid=PS+PI+PA.
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Lipid films were prepared as for LUVs and were then hydrated with 20 mM
PIPES, 1mMEDTA, 150mMNaCl with 0.002%NaN3, pH 7.40.Measurements
were made using a Nano Differential Scanning Calorimeter (Calorimetry
Sciences Corporation, American Fork, UT). The scan rate was 0.75 °C/min and
therewas a delay of 5min between sequential scans in a series to allow for thermal
equilibration. The features of the design of this instrument have been described
[9]. DSC curves were analyzed by using the fitting program, DA-2, provided by
Microcal Inc. (Northampton, MA) and plotted with Prism, version 4.01.3. Results
3.1. Role of α/β-peptides in promoting the aggregation of LUVs
We previously observed that α/β-peptide I could induce the
formation of interlamellar contacts between bilayers enriched in
PE, resulting in the formation of a morphology similar to a
bicontinuous cubic phase but without long range order [5]. Such
a morphology is referred to as a sponge phase [10]. Formation
of this phase either from LUVs or from cell membranes requires
membrane–membrane contact. We therefore monitored the
ability of these peptides to induce the aggregation of LUVs. We
have assessed the potency of α/β-peptides I and II to promote
vesicle aggregation by measuring the time dependent increaseFig. 3. (A) Aggregation of LUVs as a function of peptide concentration and different
Top panel, α/β-peptide I. Bottom panel, α/β-peptide II. The decrease in aggregation a
Aggregation of LUVs of DOPC:DOPE (2:1) containing 1 mol% of Rh-PE at 150 s af
As LUVs aggregate, more particles become visible as small dots. Top panel, α/β-pein turbidity at 436 nm after addition of one of these oligomers.
Aggregation of LUVs composed of DOPE:DOPG (2:1) occurs
very rapidly and is concentration dependent in both cases. The
rate and extent of aggregation are much greater for α/β-peptide
II than for α/β-peptide I, and significant LUV aggregation
occurs at much lower concentrations of α/β-peptide II than of
α/β-peptide I (Fig. 3A and B). Additional studies indicated that
the nature of the lipid is crucial for induced aggregation. A
smaller degree of aggregation was detected with DOPC:DOPG
(2:1) LUVs, and not much aggregation was seen with DOPC
LUVs, upon addition of up to 10 μM of either of the α/β-
peptides. Note that vesicle aggregation is required for leakage
caused by the formation of inverted phases, but is not required
for other mechanisms of peptide-induced leakage, such as pore
formation or the carpet mechanism. Therefore, α/β-peptide I
must induce hemolysis by a mechanism not involving bilayer–
bilayer contact or inverted phase formation. These results are
thus consistent with the finding that α/β-peptide I is hemolytic.
3.2. Redistribution of phospholipids in the plane of the
membrane measured by FRET
Peptide-induced segregation of lipids into domains can
destabilize the membrane by introducing phase boundarytimes studied by absorbance at 436 nm, at 30 °C, in DOPE:DOPG (2:1) LUVs.
t 300 s with α/β-peptide II reflects the clumping of some aggregated material. (B)
ter addition of α/β-peptides I or II, as seen by confocal fluorescence microscopy.
ptide I. Bottom panel, α/β-peptides II. Calibration bar is 2 μm.
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mixtures with a high content of PE, the formation of a PE-
rich domain will cause bilayer destabilization because of the
high negative curvature tendency of PE lipids. Fluorescence
resonance energy transfer (FRET) from C6-NBD-PG, C6-
NBD-PE or C6-NBD-PC to N-Rh-PE was used to assess the
ability of α/β-peptides I and II to cause segregation of PG vs.
PC or PE into domains. The N-Rh-PE was present in all
samples together with one of the two NBD-labeled lipids.
Decrease in FRET is detected as a decrease in rhodamine
fluorescence. FRET will decrease if the donor or acceptor is
sequestered into a segregated domain. The representative
anionic lipid probe is C6-NBD-PG and that for the
zwitterionic component is C6-NBD-PC or C6-NBD-PE. In
all cases the NBD group is on the acyl chain. The Rh-PE is
the common FRET acceptor for the NBD lipid probes and it
has the fluorophore on the lipid headgroup, making this lipid
anionic. If the Rh-PE is sequestered by the cationic peptide it
will decrease FRET equally with both the anionic andFig. 4. Charge segregation studied by FRET between 1 mol% N-Rh-PE and 1 m
fluorescence emission from N-Rh-PE in the absence of peptide and I the intensity in
emission intensities at 591 nm (excitation at 465 nm) were plotted as a function of the
corresponds to a series of determinations as a function of peptide concentration. This
α/β-Peptide I with either DOPC:DOPG (2:1) LUVs (top) or DOPE:DOPG (2:1) (bo
DOPG (2:1) (bottom).zwitterionic lipid probe. If the cationic peptides preferentially
sequester C6-NBD-PG, FRET with this lipid will be
decreased more than with C6-NBD-PC or C6-NBD-PE. Io
is the intensity of fluorescence emission from Rhodamine in
the absence of peptide and I the intensity in the presence of
the concentration of peptide given in the abscissa. The ratio I/
Io decreases as the peptide is added (Fig. 4). The differences
in FRET involving the probe carrying a PG headgroup
(anionic) versus a PC or PE headgroup (zwitterionic) gives an
indication of the different extents of segregation of these two
lipids induced by interaction with α/β-peptide I versus α/β-
peptide II. α/β-Peptide I altered FRET similarly for the NBD
probes having either PC, PE or PG headgroups (Fig. 4A),
indicating that there was no preferential segregation of PG
over PC or PE, either in the presence of PC or PE lipids and
therefore, for this peptide, phase boundary defects are not
expected to form in the membrane. In contrast, α/β-peptide II
was very effective at segregating PG in bilayers composed of
DOPE:DOPG (2:1), causing a much greater reduction ofol% either C6-NBD-PC, C6-NBD-PE or C6-NBD-PG. Io is the intensity of
the presence of the concentration of peptide given in the abscissa. The relative
concentration of α/β-peptide added to 50 μM LUVs. Each linear regression line
peptide titration was repeated once for each set of data giving similar results. (A)
ttom). (B) α/β-Peptide II with either DOPC:DOPG (2:1) LUVs (top) or DOPE:
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This did not occur with bilayers of DOPC:DOPG (2:1).
3.3. Extent of anionic lipid segregation revealed by DSC
For the purpose of this experiment we chose a mixture of
zwitterionic and cationic lipids, DPPE and CL that provided a
convenient signal in the DSC and was representative of two
major classes of lipids found in bacterial membranes. CL
provided a more suitable lipid mixture than PG, with
reproducible and single component phase transition behavior
in the absence of peptide. In contrast, mixtures composed of
DPPG and DPPE gave multiple peaks that exhibited variation
on repetitive scanning or between replicate samples. CL is
also one of the major lipid components of bacterial
membranes. At pH 7.4, CL carries a single negative charge
[17] as does PG. DPPE in pure form has a gel to liquid
crystalline phase transition at neutral pH at 64 °C [18], while
the tetraoleoyl form of CL has no observable transition
between 0 and 100 °C. A mixture of DPPE:CL (7:3) shows a
single, broad transition centered at about 42 °C, indicating a
miscibility between these two lipid components (Fig. 5).
Addition of 10 mol% of one of the cationic peptides alters the
phase transition properties of this lipid mixture and promotes
the formation of a component with a transition temperature at
about 60 °C, just slightly lower than the phase transition of
pure DPPE. This suggests that the cationic peptide preferen-
tially binds to the anionic lipid, CL, leaving a domain highly
enriched with DPPE. In the case of α/β-peptide I, the
component with a transition temperature of 59.4 °C has an
enthalpy of 1.9 kcal/mol, while for peptide II the component
at 58.0 °C has an enthalpy of 6.6 kcal/mol. There is a large
difference between the two α/β-peptides with regard to the
extent to which they cause the formation of this higher
melting domain, with α/β-peptide II being more potent than
α/β-peptide I.Fig. 5. Heating DSC scans of DPPE:CL (7:3) and with the addition of α/β-
peptide I or α/β-peptide II. Scan rate 0.75 °C/min, total lipid concentration
2.5 mg/mL and when present, containing 10 mol% peptide in 20 mM PIPES,
1 mMEDTA, 150 mMNaCl with 0.002%NaN3, pH 7.40. Curve 1 (Black), lipid
alone; Curve 2 (Red), with 10 mol% α/β-peptide I added; Curve 3 (Blue) with
10 mol% α/β-peptide II added. Curves have been displaced along the y-axis for
presentation. Excess heat capacity is expressed per mole of DPPE.4. Discussion
In the present study, a mechanism is proposed to explain why
α/β-peptide II is more toxic to E. coli than is α/β-peptide I. We
suggest that α/β-peptide II can promote phase segregation in
membranes composed of both anionic and zwitterionic lipid
more potently than can α/β-peptide I. This is shown by
fluorescence studies that indicate a phase segregation of anionic
and zwitterionic lipid in mixtures of DOPE:DOPG (2:1) (Fig.
4). Furthermore, we more directly demonstrate this segregation
with the use of DSC, showing that α/β-peptide II is more potent
in removing anionic lipid from a region of the membrane (Fig.
5). This phase segregation results in the formation of a domain
highly enriched in PE. This also explains our earlier finding that
α/β-peptide II induces the formation of lamellar structures in
PE/PG mixtures with a periodicity similar to that found for PE
alone and that it causes the adhesion of the inner and outer
membranes of E. coli, despite the presence of the intervening
peptidoglycan [5]. It thus provides a mechanism to explain why
α/β-peptide II is more lytic to LUVs enriched in PE [5] and is
also more toxic to E. coli [6]. The effect of α/β-peptide II to
induce lipid phase segregation is greater when the zwitterionic
lipid is PE than when it is PC (Fig. 4B) [5]. This is different
from the tendency of the lipids themselves to be miscible, as it
has been observed that PG or CL is more miscible with PE than
it is with PC in the absence of any peptide [19]. One of the
factors likely to make lipid phase segregation more toxic to
organisms with membranes rich in PE or to make liposomes that
are rich in PE more lytic is that the formation of a PE-rich
membrane domain will itself be damaging to the membrane
barrier due to the tendency of PE to form structures with
negative curvature.
Why is α/β-peptide II better at sequestering anionic lipids
than is α/β-peptide I if both peptides have the same number
of charges? Although the design of α/β-peptide I has the
charges more clustered together when the peptide forms a 14/
15 helix, α/β-peptide II has the charges more clustered along
the primary sequence. Thus, α/β-peptide II has two clusters
of positive charge at residues 3, 4 and 5 and a second small
cluster of the sequential residues 8 and 9. In contrast, α/β-
peptide I does not have 2 positively charged residues together
in the sequence. Each cationic residue of α/β-peptide I is
separated by either two or three other amino acid residues. It
is known that several proteins and peptides with clusters of
basic amino acid residues along the linear sequence can
sequester anionic lipids into domains [20–23]. Our evidence
from the FRET studies and DSC indicate that this property
extends to α/β-peptide II that similarly has clusters of
cationic residues along the sequence.
We have shown previously that α/β-peptide I, but not α/β-
peptide II, promotes the formation of a sponge phase in vesicles
enriched in PE [5]. Despite this marked change in morphology
observed with MLVs, α/β-peptide I does not cause leakage of
aqueous contents from LUVs [5]. This difference can now be
explained on the basis of the ability of this peptide to promote
vesicle–vesicle interaction. The formation of inverted phases
from liposomes is initiated by vesicle–vesicle contact [24–28].
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morphology. However, this is not the case for LUVs that do not
readily convert into inverted phases because of lack of vesicle–
vesicle contact. Vesicle–vesicle contact between LUVs can be
promoted by peptide-induced aggregation, but this process is
not as efficient with α/β-peptide I (Fig. 3A and B). Hence, α/β-
peptide I does not readily destabilize LUVs enriched in PE, as is
demonstrated by its inability to induce significant leakage in
LUVs [5]. Similar arguments can be used to explain why α/β-
peptide I is less toxic to E. coli. This peptide is unable to
promote nucleation for an inverted or sponge phase despite the
proximity of the inner and outer bacterial membrane in the
Gram negative bacteria, likely because of the intervening
peptidoglycan layer inhibiting contact between these mem-
branes and because of the weak potency of α/β-peptide I to
bring bilayers together. This is confirmed by our study of thin
sections of E. coli that showed greater separation of inner and
outer mitochondrial membranes in the presence of α/β-peptide I
[5].
The present study extends our previous work [5] and
provides a further understanding of why α/β-peptide II is more
toxic to micro-organisms with a high PE content in their
membrane as well as for the lack of toxicity of α/β-peptide I
with these cells. The work emphasizes the potential importance
of the lipid composition of the cell surface in determining
selective toxicity of anti-microbial agents.
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